A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma

Published:2014-07-28 Issue:11 Volume:49 Page:1366-1370
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Wang T-F,Fiala M A,Cashen A F,Uy G L,Abboud C N,Fletcher T,Wu N,Westervelt P,DiPersio J F,Stockerl-Goldstein K E,Vij R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2014163.pdf

Reference35 articles.

1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11–30.

2. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. New Engl J Medi 1996; 335: 91–97.

3. Attal M, Lauwers-Cances V, Marit G, Caillot D, Moreau P, Facon T et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. New Engl J Med 2012; 366: 1782–1791.

4. McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG et al. Lenalidomide after stem-cell transplantation for multiple myeloma. New Engl J Med 2012; 366: 1770–1781.

5. Blimark C, Veskovski L, Westin J, Rodjer S, Brune M, Hjorth M et al. Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation. Eur J Haematol 2011; 87: 117–122.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?;Leukemia Research;2021-08

2. Carmustine in the Therapy of B-Cell Lymphomas;Clinical oncohematology;2021

3. Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma;Bone Marrow Transplantation;2019-08-28

4. Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2017-10

5. High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients: A Phase II Study;Biology of Blood and Marrow Transplantation;2015-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3